Larson Financial Group »

Neurogene shares owned by Larson Financial Group

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $20 1 20.00

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Capital Group Global Equity SHS (CGGE)
Applied Materials (AMAT)
Vanguard Index Fds Mid Cap Etf (VO)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Msci Intl Qualty (IQLT)
Pgim Etf Tr Active Aggregate (PAB)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Microsoft Corporation (MSFT)

View all positions for Larson Financial Group

Top funds holding Neurogene

Samsara BioCapital
Redmile Group
Casdin Capital
Rtw Investments
EcoR1 Capital
BlackRock
Baker Bros. Advisors
Trails Edge Capital Partners
Balyasny Asset Management
Toronto-Dominion Bank
Jennison Associates
Arrowpoint Asset Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors

View all funds holding Neurogene